Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference (Q57210671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

title

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Suet-Lin Chia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Sally Frost

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Egon J Jacobus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Len Seymour

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Janet Lei

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

author name string

Richard Baugh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Iris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Hena Khalique

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Tzveta D Pokrovska

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

Eleanor M Scott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

William K Taverner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

language of work or name

English

0 references

publication date

4 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

page(s)

59-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

Remission of disseminated cancer after systemic oncolytic virotherapy

21 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Recombinant mumps virus as a cancer therapeutic agent

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Amplification of oncolytic vaccinia virus widespread tumor cell killing by sunitinib through multiple mechanisms.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

The evolutionary history of lethal metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Targeted BiTE expression by an oncolytic vector augments therapeutic efficacy against solid tumors

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Diverse roles of STING-dependent signaling on the development of cancer

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Intracellular Antiviral Immunity.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

The Microbiota of Breast Tissue and Its Association with Breast Cancer

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

In situ biomolecule production by bacteria; a synthetic biology approach to medicine

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Bacteria in Cancer Therapy: Renaissance of an Old Concept

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Biomimetic Salmonella: A Next-Generation Therapeutic Vector?

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

The development of a monolith-based purification process for Orthopoxvirus vaccinia virus Lister strain

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Ultrasound-Propelled Nanocups for Drug Delivery.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic parvoviruses: from basic virology to clinical applications

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma.

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis

1 reference

https://api.crossref.org/works/10.1038/S41417-018-0042-1

7 January 2021

10.1038/S41417-018-0042-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30177818 AND SRC:MED&resulttype=core&format=json

21 April 2020

1 reference